Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 18,500 | |||
5 mg | 在庫あり | ¥ 90,000 | |||
10 mg | 在庫あり | ¥ 153,500 | |||
25 mg | 在庫あり | ¥ 335,000 | |||
50 mg | 在庫あり | ¥ 454,500 |
説明 | BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections. |
別名 | BTA9881, AZD9639, AZD-9639, BTA 9881, MEDI-564 |
分子量 | 390.82 |
分子式 | C21H15ClN4O2 |
CAS No. | 1646857-24-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BTA-9881 1646857-24-0 Microbiology/Virology RSV BTA9881 AZD9639 AZD-9639 BTA 9881 MEDI564 AZD 9639 MEDI 564 MEDI-564 Inhibitor inhibitor inhibit